NASDAQ · Biotechnology

Medicus Pharma Ltd. (MDCX) Stock

$2.50 -4.58% NASDAQ: MDCX Healthcare

Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.

Valuation

Metric	Value
Price	$2.50
Market Cap	$3.59M
P/E Ratio	-0.04
P/B Ratio	-2.95
P/S Ratio	0.00
EPS (TTM)	$-1.96
52-Week High	$139.00
52-Week Low	$2.50
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-2865.18%
ROA	-204.84%
ROCE	-329.31%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	-12.27
Current Ratio	1.00

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-1.0M	$-1.0M	$-5.0M	$-11.0M	$-18.0M
Net Profit	$-2.0M	$-2.0M	$-5.0M	$-11.0M	$-25.0M
EPS	$-13.00	$-8.00	$-24.50	$-34.50	$-98.00
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$0	$0	$2.0M	$6.0M	$10.0M
Total Liabilities	$11.0M	$12.0M	$1.0M	$3.0M	$10.0M
Cash	$0	$0	$2.0M	$4.0M	$9.0M
Borrowings	$1.0M	$2.0M	$0	$0	$4.0M

Latest News

UGG's cozy bedding set is on rare sale for $70 at Macy's TheStreet · Jul 17, 2026 Emmy Predictions: What Happens When One Network Has the Two Most-Nominated Series? Variety · Jul 17, 2026 Dow Jones Futures: Micron, Sandisk, Google Lead AI Sell-Off, Netflix Dives Late; SpaceX Starship Launch Scrubbed Investor's Business Daily · Jul 17, 2026 BuzzFeed, Inc. Appoints Stanley E. Washington to Board of Directors Business Wire · Jul 17, 2026 US to Impose 25% Section 301 Tariff on Certain Brazilian Imports MT Newswires · Jul 17, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-1.0M	$-1.0M	$-4.0M	$-10.0M	$-23.0M
Investing Cash Flow	$0	$0	$0	$0	$-5.0M
Financing Cash Flow	$0	$0	$5.0M	$0	$9.0M
Net Cash Flow	$-1.0M	$0	$1.0M	$2.0M	$5.0M
Free Cash Flow	$-1.0M	$-1.0M	$-4.0M	$-10.0M	$-23.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.21
FCF Yield	-626.03%
Quick Ratio	1.57
Interest Coverage	1238.19
Return 1Y	-88.27%
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held12.48%

Institutions Held4.08%

Institutions Float Held4.67%

Institutional Holder	Shares	Report Date
Interchange Capital Partners, LLC	1,661,871	2026-03-31
Private Advisor Group, LLC	240,055	2026-03-31
Virtu Financial LLC	74,045	2026-03-31
Wilmington Savings Fund Society, FSB	51,244	2026-03-31
May Hill Capital, LLC	50,622	2026-03-31

About Medicus Pharma Ltd.

Medicus Pharma Ltd. is led by CEO Raza Bokhari, employs 12 people, headquartered in CA, publicly traded since 2024.

Medicus Pharma Ltd. (MDCX) stock trades at $2.50 with a market capitalization of $3.59M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.04, reflecting a net loss over the last twelve months, a negative price-to-book of -2.95, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.50 and $139.00, and currently trades 98.2% below its 52-week high.

On profitability, Medicus Pharma Ltd. generates a return on equity (ROE) of -2865.18% (not meaningful, as shareholders' equity is negative), return on capital employed of -329.31%.

Official website: medicuspharma.com

Medicus Pharma Ltd. by the numbers, 2021–2025

Between 2021 and 2025 Medicus Pharma Ltd. reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit fell to $-25.0M.

On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-39.0M.

Borrowings rose from $1.0M to $4.0M, cash from operations was $-23.0M in the latest year, positive in 0 of the last 5.

Return on equity has averaged -207.9% over five years, and was -366.7% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, -87.0% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Medicus Pharma Ltd. (MDCX) — frequently asked questions

What is Medicus Pharma Ltd. (MDCX) stock price today?

Medicus Pharma Ltd. (MDCX) is currently trading at $2.50, down 4.58% today.

What is MDCX P/E ratio?

Medicus Pharma Ltd.'s P/E ratio is -0.04. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is MDCX return on equity (ROE)?

Medicus Pharma Ltd.'s return on equity (ROE) is -2865.18%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is Medicus Pharma Ltd.'s market cap?

Medicus Pharma Ltd. has a market capitalization of $3.59M.

Does MDCX pay a dividend?

Medicus Pharma Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does MDCX carry?

Medicus Pharma Ltd. has a debt-to-equity ratio of -12.27. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is MDCX's profit margin?

Medicus Pharma Ltd. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.

What sector is MDCX in?

Medicus Pharma Ltd. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is MDCX listed on?

Medicus Pharma Ltd. trades on NASDAQ under the ticker MDCX.

What is MDCX's 52-week range?

Over the last year Medicus Pharma Ltd. has traded between $2.50 and $139.00.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Screens MDCX currently matches

On the figures above, Medicus Pharma Ltd. passes the filters for 2 of our ready-made screens, among them Penny Stocks, Nano Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Penny Stocks Nano Cap Stocks

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.